A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
for Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
3 locations incl. Philadelphia
Sponsor: Autolus Limited
Sex: All·Age: 0 - 18
Code: NCT06173518·Phase 1·Recruiting